Century Therapeutics (IPSC) Stock Chart & Stock Price History → Trump’s arrest is phase one (From Porter & Company) (Ad) Free IPSC Stock Alerts $2.97 -0.11 (-3.57%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Century Therapeutics Stock Price Performance5 Day Performance+2.96%1 Month Performance+7.56%3 Month Performance-14.71%6 Month Performance+128.47%Year-To-Date Performance-5.72%1 Year Performance-1.57% Receive IPSC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. IPSC Stock Chart for Friday, May, 31, 2024 IPSC Chart by TradingView Century Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2024$3.25$3.08-5.23%$3.29$3.0799,703 shs$255.18 million05/29/2024$3.30$3.25-1.52%$3.39$3.10103,486 shs$269.26 million05/28/2024$3.04$3.30+8.55%$3.38$3.00137,007 shs$273.41 million05/27/2024$3.04$3.04$3.31$2.9855,600 shs$251.86 million05/24/2024$3.12$3.04-2.56%$3.31$2.9849,610 shs$251.86 million05/23/2024$3.30$3.12-5.45%$3.33$3.0269,357 shs$202.24 million Get the Latest News and Ratings for IPSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/22/2024$2.97$3.30+11.11%$3.47$2.91187,938 shs$213.91 million05/21/2024$3.00$2.97-1.00%$3.16$2.9063,489 shs$192.51 million05/20/2024$3.01$3.00-0.33%$3.13$2.8667,380 shs$194.46 million05/17/2024$3.13$3.01-3.83%$3.19$2.9574,560 shs$195.11 million05/16/2024$3.09$3.13+1.29%$3.22$3.0362,946 shs$202.89 million05/15/2024$3.15$3.09-1.90%$3.22$3.0169,860 shs$200.29 million05/14/2024$3.00$3.15+5.00%$3.22$2.9579,567 shs$204.18 million05/13/2024$3.13$3.00-4.15%$3.20$2.9571,287 shs$194.46 million05/10/2024$3.04$3.13+2.96%$3.19$2.9869,772 shs$202.89 million05/09/2024$3.07$3.04-0.98%$3.19$2.90123,581 shs$197.05 million05/08/2024$3.37$3.07-8.90%$3.36$3.0186,653 shs$199.00 million05/07/2024$3.17$3.37+6.31%$3.67$3.12113,352 shs$218.44 million05/06/2024$3.03$3.17+4.62%$3.42$3.00100,156 shs$205.47 million05/03/2024$3.00$3.03+1.00%$3.20$2.98187,515 shs$196.41 million05/02/2024$3.04$3.00-1.32%$3.09$2.95116,134 shs$194.46 million05/01/2024$2.91$3.04+4.47%$3.13$2.96109,778 shs$197.05 million04/30/2024$3.05$2.91-4.59%$3.07$2.86166,628 shs$188.63 million04/29/2024$2.88$3.05+5.90%$3.45$2.88102,231 shs$197.70 million04/26/2024$3.15$2.88-8.57%$3.25$2.82161,095 shs$186.68 million04/25/2024$2.96$3.15+6.42%$3.17$2.85116,059 shs$204.18 million04/24/2024$3.13$2.96-5.43%$3.22$2.79134,089 shs$191.87 million04/23/2024$3.05$3.13+2.62%$3.57$2.9675,350 shs$202.89 million04/22/2024$3.09$3.05-1.29%$3.37$2.9865,688 shs$197.70 million04/19/2024$2.98$3.09+3.87%$3.20$2.91112,750 shs$200.29 million04/18/2024$2.84$2.98+4.75%$3.05$2.75145,447 shs$192.84 million04/17/2024$3.14$2.84-9.55%$3.22$2.82179,223 shs$184.09 million04/16/2024$3.67$3.14-14.44%$3.63$2.99320,555 shs$203.54 million04/15/2024$3.91$3.67-6.14%$3.99$3.6342,066 shs$237.89 million04/12/2024$4.05$3.91-3.46%$4.07$3.64115,200 shs$253.45 million04/11/2024$3.78$4.05+7.14%$4.43$3.80248,494 shs$262.52 million04/10/2024$4.01$3.78-5.74%$4.00$3.6094,887 shs$245.02 million04/09/2024$3.78$4.01+6.08%$4.05$3.6879,877 shs$259.93 million04/08/2024$3.63$3.78+4.13%$3.84$3.51211,525 shs$245.01 million04/05/2024$3.64$3.63-0.27%$3.74$3.6027,552 shs$235.30 millionTrump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.04/04/2024$3.70$3.64-1.62%$3.87$3.6372,518 shs$235.94 million04/03/2024$3.79$3.70-2.37%$3.86$3.6192,414 shs$239.83 million04/02/2024$4.05$3.79-6.42%$3.94$3.74117,581 shs$245.67 million04/01/2024$4.18$4.05-3.11%$4.19$4.0182,632 shs$262.52 million03/29/2024$4.18$4.18$4.39$4.05173,391 shs$270.95 million03/28/2024$4.27$4.18-2.11%$4.32$4.05173,391 shs$270.95 million03/27/2024$3.98$4.27+7.29%$4.39$3.86255,975 shs$276.78 million03/26/2024$4.01$3.98-0.75%$4.06$3.9393,286 shs$257.98 million03/25/2024$4.43$4.01-9.48%$4.50$4.00206,281 shs$259.93 million03/22/2024$4.78$4.43-7.32%$4.78$4.41108,458 shs$287.15 million03/21/2024$5.01$4.78-4.59%$5.24$4.75102,513 shs$309.84 million03/20/2024$4.80$5.01+4.38%$5.18$4.7386,450 shs$324.75 million03/19/2024$4.75$4.80+1.05%$4.87$4.5392,203 shs$311.13 million03/18/2024$5.00$4.75-5.00%$5.12$4.7567,863 shs$284.19 million03/15/2024$4.51$5.00+10.86%$5.05$4.81262,376 shs$299.15 million03/14/2024$4.86$4.51-7.20%$4.84$4.34137,628 shs$269.86 million03/13/2024$4.75$4.86+2.32%$4.90$4.68105,202 shs$290.77 million03/12/2024$5.16$4.75-7.95%$5.29$4.61128,627 shs$284.19 million03/11/2024$5.24$5.16-1.53%$5.39$4.96146,155 shs$308.72 million03/08/2024$5.32$5.24-1.41%$5.51$5.03133,976 shs$313.51 million03/07/2024$5.00$5.32+6.30%$5.50$4.80232,653 shs$318.00 million03/06/2024$4.25$5.00+17.65%$5.07$4.36285,561 shs$299.15 million03/05/2024$4.10$4.25+3.66%$4.34$4.0685,484 shs$254.28 million03/04/2024$3.96$4.10+3.54%$4.19$3.92109,547 shs$245.30 million03/01/2024$3.67$3.96+7.90%$4.00$3.54168,105 shs$236.93 million02/29/2024$3.47$3.67+5.76%$3.76$3.45103,226 shs$219.59 million Related Companies: IVVD Stock Price Chart NKTX Stock Price Chart BLUE Stock Price Chart ALVR Stock Price Chart KRON Stock Price Chart VAXX Stock Price Chart IMTX Stock Price Chart MESO Stock Price Chart RLAY Stock Price Chart HUMA Stock Price Chart Receive IPSC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPSC) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.